pc70bm n type thin film transistors influence of hmds deposition temperature on the devices properties

This study investigates the influence of the deposition temperature of hexamethyldisilazane (HMDS) on the performances of organic thin film transistors (OTFTs) using the [6,6]-phenyl-C71-butyric acid methyl ester (PC70BM) as semiconductor. N-type OTFTs have been fabricated using this fullerene derivative, deposited from solution by drop casting technique on HMDS self-assembled monolayer (SAM) deposited at three different temperatures, 7 °C, 25 °C and 60 °C, in order to evaluate the influence of these deposition conditions on the morphology of PC70BM films and on the electrical responses of fullerene derivative-based OTFTs. The effect of the treatments of the surfaces was observed through contact angle measurements. AFM imaging of the deposited material has been used to analyse its structure and morphology. The transistors performances have been evaluated through I vs. V static characterization and parameters extraction. Contact angle vs. HMDS deposition temperature shows the minimum value at 60 °C, instead here field effect mobility presents a maximum. It has been observed that the lower hydrophobicity of the surface of the SAM induces the formation of more homogeneous surface of the PC70BM film, resulting in an increase of the OTFTs performances

analysis of hmds self assembled monolayer effect on trap density in pc70bm n type thin film transistors through admittance studies

Abstract In this work, n-type organic thin film transistors (OTFTs) were fabricated in the bottom-gate bottom-contact configuration, depositing a fullerene-derived semiconductor (PC 70 BM) by drop-casting technique on SiO 2 substrates treated with a self-assembled monolayer, namely the HMDS. The influence of the deposition temperature of the HMDS on the device performance was investigated, using three different temperatures. The relationship between the properties of the resulting semiconductor films and the electrical characteristics of the transistors was evaluated through admittance measurements. The frequency response of the devices vs. the bias was interpreted applying an electrical equivalent circuit to model the properties of the semiconductor and of the transistor conductive channel. The proposed model shows the critical role played by the quality of the insulator-semiconductor interface on the traps density in the semiconductor, and therefore on the increase of the mobility and on the reduction of the threshold voltage of the transistors

A microRNA prognostic signature in patients with diffuse intrinsic pontine gliomas through non-invasive liquid biopsy

Diffuse midline gliomas (DMGs) originate in the thalamus, brainstem, cerebellum and spine. This entity includes tumors that infiltrate the pons, called diffuse intrinsic pontine gliomas (DIPGs), with a rapid onset and devastating neurological symptoms. Since surgical removal in DIPGs is not feasible, the purpose of this study was to profile circulating miRNA expression in DIPG patients in an effort to identify a non-invasive prognostic signature with clinical impact. Using a high-throughput platform, miRNA expression was profiled in serum samples collected at the time of MRI diagnosis and prior to radiation and/or systemic therapy from 47 patients enrolled in clinical studies, combining nimotuzumab and vinorelbine with concomitant radiation. With progression-free survival as the primary endpoint, a semi-supervised learning approach was used to identify a signature that was also tested taking overall survival as the clinical endpoint. A signature comprising 13 circulating miRNAs was identified in the training set (n = 23) as being able to stratify patients by risk of disease progression (log-rank p = 0.00014; HR = 7.99, 95% CI 2.38–26.87). When challenged in a separate validation set (n = 24), it confirmed its ability to predict progression (log-rank p = 0.00026; HR = 5.51, 95% CI 2.03–14.9). The value of our signature was also confirmed when overall survival was considered (log-rank p = 0.0021, HR = 4.12, 95% CI 1.57–10.8). We have identified and validated a prognostic marker based on the expression of 13 circulating miRNAs that can shed light on a patient’s risk of progression. This is the first demonstration of the usefulness of nucleic acids circulating in the blood as powerful, easy-to-assay molecular markers of disease status in DIPG. This study provides Class II evidence that a signature based on 13 circulating miRNAs is associated with the risk of disease progression